Exothera

Exothera is a leading contract research, development, and manufacturing organization (CDMO) that focuses on the production of viral vectors and nucleic acids. As a part of the Univercells group, Exothera leverages innovative manufacturing technologies to deliver top-notch bioprocessing expertise. The company's offerings include accelerated discovery services, process development, and optimization aimed at swiftly achieving GMP clinical and commercial production of viral vectors and nucleic acids. Exothera benefits from the support of Univercells and its advanced manufacturing technologies. The company tailors its services to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. With a keen eye on cost-effectiveness and operational agility, Exothera aptly selects technologies to meet the unique needs of its customers. Founded in 2020, Exothera is committed to advancing life-changing therapies and making them accessible to all. The company's dedication to technological innovation and bioprocessing excellence positions it as a key player in the field of viral vector and nucleic acid development and manufacturing services. Company number: 0744643660 VAT: BE0744643660